tradmap

PMI Financials Picard Medical, Inc.

2 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 12.5% per year over the past 1 years.
  • Operating margin has expanded, at -268.4% in the latest year.
Revenue & net income
-$27M -$11M $5M $0 2024 2025
RevenueNet income
Margins (gross / operating / net)
-547% -273% 0% 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $1 $1 2024 2025
Free cash flow
Cash vs total debt
$0 $4M $7M 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$16M $6M $27M $0 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $5M -$27M -4.1% -268.4% $7M
2024 $4M -$21M -2.6% -312.3% $96000

Valuation over time

How the market has priced PMI against its own fundamentals since 2025-08 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 90.5 181.1 Aug '25 Oct '25 Dec '25 Feb '26 Apr '26 Jun '26
P/S

Frequently asked questions

Is PMI growing its revenue and profit?

Over the past 1 years, Picard Medical, Inc.'s revenue has grown 12.5% per year. These are computed facts, not advice.

How much debt does PMI have?

As of FY2025, Picard Medical, Inc. reported — of total debt against $7M of cash.

What is PMI's profit margin?

In FY2025, gross margin was -4.1%, operating margin -268.4%, and net margin -546.6%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.